Found 307 results for oasmia-pharmaceutical

Custom crystal celebrating the submission of a New Drug Application (NDA) to the Food and Drug Administration (FDA). The application, related to Impel NeuroPharma’s migraine treatment INP104, was supported by a Phase 3, open-label STOP-301 Trial.

Crystal deal toy celebrating the initial public offering by pharmaceutical firm Rua Bioscience. The New Zealand-based company is licensed to produce cannabis-derived medicines.

Crystal deal toy, incorporating an interior, 3-D etching of Thor’s hammer, commemorating a private placement by pharmaceutical company Photocure ASA. Based in Oslo, Norway, Photocure specializes in photodynamic therapies that make use of light-activated drugs.

Crystal deal toy commemorating the acquisition of Philadelphia-based Spark Therapeutics. The acquiring firm, Swiss pharmaceutical firm Roche, is headquartered in Basel.

Lucite tombstone celebrating a private placement and concurrent global offering of shares by Calliditas Therapeutics. Joint bookrunners in the offering by the Swedish biotech firm were Citi, Jefferies, and Stifel.

Financial tombstone marking the successful placement by Siegfried Holding of a senior bond. The Swiss firm provides development and production services to the pharmaceutical and life sciences sectors.

Lucite embedment with drug vial commemorating a study of a treatment for solid tumor cancer.

Custom Lucite with Drug Vial

Crystal deal toy marking the sale of Bova Holdings to Vimian Group’s Specialty Pharma division. Bova is the UK’s largest companion animal pharmaceutical company, serving veterinary clinics and animal hospitals.